solifenacin succinate has been researched along with warfarin in 1 studies
| Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 522 | 194 | 343 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | solifenacin succinate (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krauwinkel, WJ; Kuipers, ME; Smulders, RA | 1 |
1 trial(s) available for solifenacin succinate and warfarin
| Article | Year |
|---|---|
Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.
Topics: Administration, Oral; Adult; Anticoagulants; Area Under Curve; Cardiotonic Agents; Digoxin; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Warfarin | 2006 |